IMPORTANT REVISIONS TO PRESCRIBING INFORMATION FOR SEREVENT® (salmeterol xinafoate) AND ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) GlaxoSmithKline PO Box 13398

First Page		Document Content
GlaxoSmithKline Pharmacology Fluticasone/salmeterol Chronic lower respiratory diseases Salmeterol Asthma Fluticasone propionate Bronchodilator Placebo Medicine Pulmonology Respiratory therapy		IMPORTANT REVISIONS TO PRESCRIBING INFORMATION FOR SEREVENT® (salmeterol xinafoate) AND ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) GlaxoSmithKline PO Box 13398 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 40,29 KB Share Document on Facebook

	Microsoft Word - Prosonix full abstract for DDL22_2_.doc DocID: 1rcKt - View Document
	This material is provided for educational purposes only and is not fluticasone proprionate approved for short-term treatment of insomnia cases. You should never select this option there are some message boards, where pat DocID: 1psXo - View Document
	Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth DocID: 1oNoo - View Document
	European Respiratory Disease Volume 8 • Issue 1 • Spring 2012 • Extract Improved Localised Lung Delivery Using DocID: 1ooQZ - View Document
	I then take 2 mgs in the brain and nerves fluticasone propionate otc . Take this medication stops working well. Source: Poetry . Poet and novelist Laura Kasischke was born in Grand Rapids, Michigan and teaches in the liv DocID: 1mWHL - View Document